Climb Bio Inc (CLYM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -18,601 | -20,668 | -5,805 | -3,547 |
| Accounts payable and accrued liabilities | 917 | N/A | 82 | -381 |
| Other Working Capital | -73 | -2,936 | -2,962 | -2,621 |
| Other Operating Activity | 11,017 | 9,506 | 211 | 456 |
| Operating Cash Flow | $-6,740 | $-14,098 | $-8,474 | $-6,093 |
| Cash Flows From Investing Activities | ||||
| Other Investing Activity | 0 | 8,078 | 0 | 0 |
| Investing Cash Flow | $0 | $8,078 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 105 | N/A | N/A | N/A |
| Other Financing Activity | 33,978 | 4,925 | 0 | 0 |
| Financing Cash Flow | $34,083 | $4,925 | $N/A | $N/A |
| Exchange Rate Effect | 81 | 359 | -59 | 110 |
| Beginning Cash Position | 20,487 | 21,223 | 21,223 | 21,223 |
| End Cash Position | 47,911 | 20,487 | 12,690 | 15,240 |
| Net Cash Flow | $27,424 | $-736 | $-8,533 | $-5,983 |
| Free Cash Flow | ||||
| Operating Cash Flow | -6,740 | -14,098 | -8,474 | -6,093 |
| Free Cash Flow | -6,740 | -14,098 | -8,474 | -6,093 |